Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET
Rhea-AI Summary
Agios (Nasdaq: AGIO) will hold a conference call and live webcast on April 29, 2026 at 8:00 a.m. ET to report first quarter 2026 financial results and business highlights.
The live webcast will be available on the company’s Investors site under Events & Presentations, and a replay will be posted approximately two hours after the event.
Positive
- None.
Negative
- None.
News Market Reaction – AGIO
In the Apr 6 session, AGIO declined 1.14%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Conferences,earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 26 | Earnings call notice | Neutral | +1.0% | Announced Q4 and full-year 2025 results call with webcast replay details. |
| Oct 16 | Earnings call notice | Neutral | +0.3% | Set date and time for Q3 2025 financial results call and webcast. |
| Jul 14 | Earnings call notice | Neutral | +0.5% | Announced Q2 2025 financial results conference call and webcast schedule. |
| Apr 17 | Earnings call notice | Neutral | +1.9% | Scheduled Q1 2025 financial results webcast and business update call. |
| Feb 06 | Earnings call notice | Neutral | +0.1% | Outlined timing for Q4 and full-year 2024 financial results webcast. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Scheduling earnings calls has historically coincided with small, generally positive price moves.
Over the past year, AGIO has repeatedly issued "conference call and webcast" notices for quarterly and annual results, all tagged as conferences,earnings. These events, from Feb 13, 2025 through Feb 12, 2026, consistently outlined timing and access details, with modest positive next-day price reactions between 0.12% and 1.92%. Today’s Q1 2026 call announcement follows the same established communications pattern.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CAMBRIDGE, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced the company will host a conference call and live webcast on Wednesday, April 29, 2026, at 8:00 a.m. ET to report its first quarter 2026 financial results and business highlights.
The live webcast will be accessible on the Investors section of the company’s website (www.agios.com) under the “Events & Presentations” tab. A replay of the webcast will be available on the company’s website approximately two hours after the event.
About Agios: Fueled by Connections to Transform Rare Diseases™
At Agios, our vision is to redefine the future of rare disease treatment. Fueled by connections, we build trusted partnerships with communities – collaborating to develop and deliver innovative medicines that have the potential to transform lives. With a foundation in hematology, we combine biological expertise with real-world insights to advance a growing pipeline of rare disease medicines that reflect the priorities of the people we serve. Agios is a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts. To learn more, visit www.agios.com and follow us on LinkedIn and X.
Available Information about Agios
To achieve broad dissemination, Agios may disclose information to the public through a variety of disclosure channels including press releases, SEC filings, and public conference calls and webcasts. Some of the information distributed through these disclosure channels may be considered material information. Investors and others should note that Agios plans to use its website (www.agios.com) as a distribution channel to announce and give notice of Agios’ upcoming events and presentations (including, but not limited to, presentations at medical or healthcare conferences). Such information, which may be deemed material, will be available on the Investors section of the company’s website under the “Events & Presentations” tab. In addition, you may sign up to automatically receive email alerts about Agios’ upcoming events and presentations (“Calendar Alerts”) by visiting the “Email Alerts” option under the “IR Resources” tab of the Investors section of the company’s website and submitting your email address.
Contacts:
Investor Contact
Morgan Sanford, Vice President, Investor Relations
Agios Pharmaceuticals
morgan.sanford@agios.com
Media Contact
Eamonn Nolan, Senior Director, Corporate Communications
Agios Pharmaceuticals
eamonn.nolan@agios.com
